Durhane Wong-Rieger, President & CEO of the Canadian Organization for Rare Disorders, joins Natalie Yeadon, Co-Founder & CEO at Impetus Digital. We explore how to best involve patients in all aspects of the drug lifecycle, innovative approaches to drug access and financing, and other topics related to rare disease treatment and advocacy.
Schedule a meeting with Natalie Yeadon: https://www.meetwithnatalie.com
Natalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/
Impetus Digital Website: https://www.impetusdigital.com/
Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/
Impetus Digital Twitter: https://twitter.com/Impetusadboards
Impetus YouTube: https://www.youtube.com/Impetushealthcare
Durhane Wong-Rieger: https://www.linkedin.com/in/durhane-wong-rieger-5851b39/
Canadian Organization for Rare Disorders: http://www.raredisorders.ca/
Durhane Wong-Rieger, President & CEO of the Canadian Organization for Rare Disorders, joins Natalie Yeadon, Co-Founder & CEO at Impetus Digital. We explore how to best involve patients in all aspects of the drug lifecycle, innovative approaches to drug access and financing, and other topics related to rare disease treatment and advocacy.
Schedule a meeting with Natalie Yeadon: https://www.meetwithnatalie.com
Natalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/
Impetus Digital Website: https://www.impetusdigital.com/
Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/
Impetus Digital Twitter: https://twitter.com/Impetusadboards
Impetus YouTube: https://www.youtube.com/Impetushealthcare
Durhane Wong-Rieger: https://www.linkedin.com/in/durhane-wong-rieger-5851b39/
Canadian Organization for Rare Disorders: http://www.raredisorders.ca/